116 related articles for article (PubMed ID: 6161054)
21. The role of immune complexes for the origin of liver lesions.
Horejsí J
Czech Med; 1984; 7(1):1-14. PubMed ID: 6723476
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
23. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
Madalinski K; Burczynska B; Heermann KH; Uy A; Gerlich WH
Clin Exp Immunol; 1991 Jun; 84(3):493-500. PubMed ID: 2044231
[TBL] [Abstract][Full Text] [Related]
24. [Antigen-specific detection and assay of serum HBsAG-AB-immune complexes in HBV carriers (author's transl)].
Tsuji T; Tsuchiya M; Araki K; Shinohara T; Onoe K
Nihon Shokakibyo Gakkai Zasshi; 1980 May; 77(5):806. PubMed ID: 6157039
[No Abstract] [Full Text] [Related]
25. Prognostic value of HBsAg/IgM complexes in hepatitis B patients: nature of the proteins involved.
Grangeot-Keros L; Pelletier G; Briantais MJ; Pillot J
J Med Virol; 1988 Jul; 25(3):309-15. PubMed ID: 3171555
[TBL] [Abstract][Full Text] [Related]
26. Characterization of antigen moiety of HBsAg in the complement fixing immune complexes of hepatitis B virus positive chronic active hepatitis.
Gupta RC
Clin Exp Immunol; 1982 Sep; 49(3):543-51. PubMed ID: 7172494
[TBL] [Abstract][Full Text] [Related]
27. Immunoelectron microscopic observation of hepatitis B surface antigen on the surface of liver cells from patients with hepatitis B virus infection.
Yamada G; Takahashi T; Mizuno M; Sakamoto Y; Kaga K; Kobayashi T; Nagashima H
Acta Med Okayama; 1980 Jun; 34(3):175-87. PubMed ID: 6447986
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique.
Aoki M; Saito T; Watanabe H; Matsuo T; Saito K; Togashi H; Kawata S; Ishikawa K; Aoyama M; Kamada H; Shinzawa H
J Med Virol; 2002 Feb; 66(2):166-70. PubMed ID: 11782924
[TBL] [Abstract][Full Text] [Related]
29. A monoclonal antibody enzyme immunoassay for the detection of epitopes encoded by the pre-S2 region of the hepatitis B virus genome.
Budkowska A; Dubreuil P; Riottot MM; Briantais MJ; Pillot J
J Immunol Methods; 1987 Feb; 97(1):77-85. PubMed ID: 2434570
[TBL] [Abstract][Full Text] [Related]
30. Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test.
Sansonno DE; Detomaso P; Primavera MV; Papanice MA; Donnaloia R; Manghisi OG
J Virol Methods; 1986 Sep; 14(2):141-51. PubMed ID: 3771731
[TBL] [Abstract][Full Text] [Related]
31. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?
Heijtink RA; van Hattum J; Schalm SW; Masurel N
J Med Virol; 1982; 10(2):83-90. PubMed ID: 6183398
[TBL] [Abstract][Full Text] [Related]
32. A study of the evolution of specific and non-specific immune complexes in acute hepatitis B and chronic hepatitis.
Leyva A; Bernal MC; Piedrola G; Maroto MC
J Med Microbiol; 1988 Jul; 26(3):237-9. PubMed ID: 3392730
[TBL] [Abstract][Full Text] [Related]
33. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the radioimmunological and immunoenzymatic methods in detection of HBsAg].
Nocera A; Barocci S
Boll Soc Ital Biol Sper; 1979 Nov; 55(22):2337-40. PubMed ID: 398703
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
Anh-Tuan N; Novák E
Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
[TBL] [Abstract][Full Text] [Related]
36. HBsAg/IgM complexes as a prognostic marker of chronicity in acute hepatitis B virus infection.
Ljunggren K; Hansson BG; Nordenfelt E
Scand J Infect Dis; 1991; 23(5):529-34. PubMed ID: 1767250
[TBL] [Abstract][Full Text] [Related]
37. Difference of subtypes of hepatitis B surface antigen between asymptomatic carriers and patients with chronic liver diseases.
Nakamura S; Takezawa Y; Maeda T
Tohoku J Exp Med; 1980 Nov; 132(3):367-8. PubMed ID: 6162245
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the circulating immune complexes in acute and chronic liver diseases.
Schena FP; Pastore G; Pastore A; Angarano G; Meliconi L; Schiraldi O; Bonomo L
J Clin Lab Immunol; 1983 Apr; 10(4):179-83. PubMed ID: 6864764
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus infection: detection of circulating HBsAg/IgM antibody immune complexes.
Surelia P; Boxall EH
Med Lab Sci; 1990 Jul; 47(3):204-9. PubMed ID: 2402200
[TBL] [Abstract][Full Text] [Related]
40. Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
Petit MA; Zoulim F; Capel F; Dubanchet S; Dauguet C; Trepo C
Hepatology; 1990 May; 11(5):809-14. PubMed ID: 2347555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]